Ashvani Singh
Senior Principal Research Scientist, Abbvie, USA
BrazMedChem 2025 back to
Rio de Janeiro after 9 years
XII BrazMedChem 2025 – 20-24th september
Búzios Rio de Janeiro – Brazil
Medicinal Chemistry: rescuing the empowerment of science to promote human health.
Presentation
Theme: “Medicinal Chemistry: rescuing the empowerment of science to promote human health”
Aiming to organize a scientifically
Memorable event against the magnificent natural scenes of RJ (which few places in the world can rival)
Promote social interactions
Pleasant and culturally stimulating environment
Bring together
A large number of internationally renowned scientists
Facilitate access
Facilitate access to students and researchers from all regions of Brazil
Language
The official language of BrazMedChem2025 is English
Official hotel
Hotel Atlântico, Búzios-RJ https://www.atlanticobuzios.com.br/
Speakers
Continue Reading
Dr. Bahne Stechmann
Deputy Director
EU-OPENSCREEN ERIC
“Putting your compounds to good use: EU-OPENSCREEN’s open compound sharing initiative”
Dr. David R. Spring
Professor of Chemistry and Chemical Biology
Yusuf Hamied Department of Chemistry
University of Cambridge
“Next Generation Antibody-Drug Conjugates”
Dr. Laura Simpson
Drug Discovery Unit, University of Dundee
“DMPK Challenges and Opportunities in Malaria Drug Discovery”
Dr. Paul C. Trippier
University of Nebraska
“TBD”
James Duffy
Medicines for Malaria Venture
“Replenishing the malaria drug discovery pipeline: Advances in Hit Generation for Antimalarial Drug Discovery”
Prof. Dr. Stefan Wölfl
University of Heidelberg
“Microfluidic “organ-on-a-chip” tissue culture model systems
for drug testing and toxicity studies”
Prof. Emeritus Ronald J. Quinn
AM, FTSE – Griffith University
“Approaches for Natural Product Drug Discovery from compound libraries to Hit Identification”
Prof. Susan Wyllie
Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee
“The direct approach: the role of chemical proteomics in drug target deconvolution”
More Information
The official language of BrazMedChem2025 is English. All abstracts and panels should be written in English. The official language of Brazil is Portuguese.
Official hotel: Atlântico Búzios Convention, Búzios-RJ
- Room rates:
- Single
- Double
- Triple
- For booking contact: Creacteve Eventos | creacteve@creacteve.com.br | WhatsApp: + 55 21 99557 0582
Check the link for exclusive values for the event.
Accommodations Info
Reservations at the Hotel Atlântico Buzios can be made online here.
We advise you to book accommodation as soon as possible, as availability is limited.
Hotel Atlantico Buzios
The Hotel Atlântico Buzios Convention is located in the town of Armação dos Búzios, 166 km from Rio de Janeiro. Situated on Armação Beach, and surrounded by a unique natural landscape.
With a privileged location, with exits to Orla Bardot, from the hotel you can easily reach Rua das Pedras and some of the city’s most charming beaches.
Organizing Committee
- Dr. Floriano Paes Silva Junior – Chair (FIOCRUZ, Rio de Janeiro-RJ)
- Dra. Lídia Moreira Lima – Chair (UFRJ, Rio de Janeiro-RJ)
- Dr. Arthur Kummerle (UFRRJ, Rio de Janeiro-RJ)
- Dr. Carlos Maurício (UFRRJ, Rio de Janeiro-RJ)
- Dra. Luzineide Tinoco (UFRJ, Rio de Janeiro-RJ)
- Dra. Sabrina Ferreira (UFRJ, Rio de Janeiro-RJ)
Scientific Committee
- Glaucius Oliva – USP, São Carlos-SP (President)
- Rafael Guido – USP, São Carlos-SP (President)
International
- Stefan Laufer, President of DPhG and Chairman Pharmaceutical / Medicinal Chemistry (Institute of Pharmacy), Germany (Coordinator)
- Anna Juncker, Vice President of DPhG, Werner Siemens Imaging Center, Germany
- Luc van Hijfte, President EFMC, Symeres, Senior Director, The Netherlands
- Gunda Georg, Chairwoman MedChem Division ACS, USA
- Maria Laura Bolognesi, University of Bologna, Italy
- Jean Quancard, Chairman Best Practice Working Group of EFMC, Novartis, Switzerland
Brazilian
- Andrei Leitão – University of São Paulo at São Carlos
- Ângelo de Fátima – Federal University of Minas Gerais
- Claudio Viegas Jr – Federal University of Alfenas
- Christiano Guimarães – Nintx – Next Innovative Therapeutics
- Daniela Barretto Barbosa Trivella – Biosciences National Laboratory
- Fernanda Guilhon Simplicio – Federal Univesity of Amazonas
- Flavio da Silva Emery – University of São Paulo at Ribeirão Preto
- Gustavo Trossini – University of São Paulo
- Hugo Verli – Federal University of Rio Grande do Sul
- Isabella Alvim Guedes – National Laboratory of Scientific Computing
- Jean Leandro dos Santos – São Paulo State University
- João Paulo S. Fernandes – Federal University of São Paulo
- Luiz Carlos Dias – Campinas State University
- Luis Octavio Regasini – State University of São Paulo
- Magaly Girão Albuquerque – Federal University of Rio de Faneiro
- Marcela Cristina de Moraes – Fluminense Federal University
- Marcelo Santos Castilho – Federal University of Bahia
- Marco Edilson Freire de Lima – Federal Rural University of Rio de Faneiro
- Maria Cristina Nonato – University of São Paulo at Ribeirão Preto
- Marilia Valli – University of São Paulo at Ribeirão Preto
- Nailton M. Nascimento Júnior – State University of São Paulo
- Nubia Boechat – Oswaldo Cruz Foundation
- Rafaela Salgado Ferreira – Federal University of Minas Gerais
- Vitor Francisco Ferreira – Fluminense Federal University
Secretariat
Creacteve Eventos creacteve@creacteve.com.br
WhatsApp + 55 21 99557 0582
Registration and Abstract submission
Accessing registration systems
Special conditions for students and early birds!
Preliminary Program
| Time | September 20th (Saturday) | September 21st (Sunday) | September 22nd (Monday) | September 23rd (Tuesday) | September 24th (Wednesday) |
|---|---|---|---|---|---|
| 8:00 – 12:00 | Three Short-Courses: 1. Drug Discovery Weekend 2. Boas práticas de simulações moleculares 3. Integrative Structural Biology |
Tematic Session I AI in Drug Discovery 9:00-9:40 Laurent Dardenne (LNCC) 9:40-10:20 Speaker (TBD) 10:50-11:20 Speaker (TBD) |
Round Table: “New Challenges in the Brazilian Pharma Industry” 9:00-11:00 Mediator: Glaucius Oliva Debaters: Marco Krieger, Maria Augusta Aruda (LNBio), Marta Pena |
Tematic Session IV New Trends in Drug Discovery 9:00-9:40 Paul C. Trippier (University of Nebraska) 9:40-10:20 Stefan Wolf (University of Heidelberg) |
|
| 9:00 – 12:20 | |||||
| 12:00 – 13:00 | Lunch | Lunch | Lunch | Lunch | |
| 13:00 – 17:00 | Three Short-Courses: 1. Drug Discovery Weekend 2. Boas práticas de simulações moleculares 3. Integrative Structural Biology Coffee-break 15:15 – 15:30 |
Symposium Young Medicinal Chemistry Coffee-break 15:15 – 15:30 |
Lecture: 14:00-15:00 Stefan Knapp (Frankfurt University) 15:00-16:00 James Duffy (MMV) Coffee + Poster Session I |
Lecture: 14:00-15:00 David Spring (University of Cambridge) 15:00-16:00 Lecture 4 (TBD) |
|
| 16:30 – 18:30 | Coordinated Sessions: Session 1: Sabrina B. Ferreira Session 2: Carlos Maurício Santana |
Coordinated Sessions: Session 3: Arthur Kummerle Session 4: Luzinelde Tinoco |
|||
| 17:30 – 19:30 | SBQ MedChem Division Meeting | Closing Ceremony | |||
| 19:30 – 21:30 | Welcome Reception | Dinner Confraternization | Social Event: Pool Party/Lual | Confraternization |
More information for the application process here
Visa
Visas to enter Brazil are granted by the Brazilian consulates abroad. Citizens of countries that are members of the Mercosul do not require visas, only a valid passport or valid identity document are required.
To learn more about the documentation and procedures for granting visas, see the Brazilian embassy/consulate in your country of origin.
Also check out here for further information on Brazilian Visa.
Citizens travelling with passports from Australia, Canada and the United States visiting Brazil for tourism and business will be subject to visa requirements for entry into Brazilian territory starting from April 10th, 2024. These citizens can require e-Visas through the portal https://brazil.vfsevisa.com/. The process is easy, and quick and if the requirements mentioned below are met, in a few days the applicant will receive the e-Visa on his or her e-mail.
